# Treace Medical Concepts, Inc. Common Stock (TMCI)

> Treace Medical Concepts, Inc. Common Stock (TMCI) trades at $4.44 (+0.45%) as of 7:30:02 PM EST on Nov 17, 2026, +14.43% over the past month. Market cap is $289.77M, with 8.7 days to cover in short interest.

Canonical: https://massive.com/quote/tmci
Data as of: 2026-11-18T00:30:02.680Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$4.44** +0.02 (+0.45%)
As of 7:30:02 PM EST on Nov 17, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Treace Medical Concepts, Inc. Common Stock (TMCI) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | +0.45% |
| 1W | -9.02% |
| 1M | +14.43% |
| YTD | +81.22% |
| 1Y | +59.14% |
| 52-wk range | $1.17 – $5.44 |

From daily closes through Nov 17, 2026.

## Key statistics

Today's trading snapshot for TMCI: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $4.37 – $4.63 |
| Open | $4.44 |
| Prev close | $4.42 |
| Volume | 292.35K |
| Market cap | $289.77M |
| Shares out | 65.56M |

## Valuation and profitability ratios

Valuation and profitability ratios for Treace Medical Concepts, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 1.43 |
| P/B | 4.70 |
| P/FCF | — |
| ROE | -90.6% |
| ROA | -31.1% |
| Debt/Equity | 0.91 |
| Div yield | 0.00% |

As of Nov 16, 2026

## Insider trading

[Treace Medical Concepts, Inc. Common Stock (TMCI) insider trading](https://massive.com/quote/tmci/insider-trading.md): open-market Form 4 buys and sells by Treace Medical Concepts, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Treace Medical Concepts, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 6, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 6, 2026, Treace Medical Concepts, Inc. (the "Company") issued a press release regarding its financial results for the quarter ended September 30, 2026.”
- May 20, 2026 · Annual meeting results
  “At the 2026 Annual Meeting of Stockholders (the "Meeting") of Treace Medical Concepts, Inc. (the "Company") held on May 19, 2026, the stockholders of the Company voted on the following proposals... The results of voting on the three proposals, including final voting tabulations, are set forth below.”
- Apr 9, 2026 · [Guidance issuance or update](https://massive.com/quote/sec-filings/8-k/guidance-updates.md)
  “The Company is updating its full-year 2026 revenue guidance to $202 million to $212 million. This compares to previous full-year guidance of $200 million to $212 million. The Company's updated full-year 2026 guidance reflects continued case volume growth, offset by previously disclosed headwinds from demand driven product and price mix shift within the Company's expanded bunion portfolio.”
- Jan 13, 2026 · [Preliminary results](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On January 13, 2026, Treace Medical Concepts, Inc. (the "Company") issued a press release regarding certain preliminary unaudited financial results for the quarter and the year-ended December 31, 2025.”
- Dec 18, 2025 · Debt retirement
  “On December 17, 2025, in connection with the Company's entry into the Loan Agreements discussed in Item 1.01 of this Report, the Company used proceeds from the new term loan to pay the outstanding balance and fees under, and subsequently terminated, (1) the Credit and Security Agreement (Term Loan) with MidCap Financial Trust and (2) the Credit and Security Agreement (Revolving Loan) with MidCap Funding IV Trust and lenders thereto (collectively, the "MidCap Loan Agreements"). As provided in the MidCap Loan Agreements, the Company paid prepayment and exit fees totaling $2.3 million for the term and revolving loans.”

## TMCI short interest

How heavily TMCI is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 8.7 |
| Short interest | 1.79M |
| Avg volume | 206.95K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## TMCI news

The latest news and headlines about Treace Medical Concepts, Inc. Common Stock (TMCI).

- [Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates](https://www.zacks.com/stock/news/3025276/treace-medical-concepts-tmci-reports-q3-loss-tops-revenue-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3025276) · Zacks Investment Research · Nov 6, 2026 · positive sentiment
- [Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Beats Revenue Estimates](https://www.zacks.com/stock/news/3024862/tandem-diabetes-care-inc-tndm-reports-q3-loss-beats-revenue-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3024862) · Zacks Investment Research · Nov 5, 2026 · negative sentiment
- [UFP Technologies (UFPT) Q3 Earnings and Revenues Surpass Estimates](https://www.zacks.com/stock/news/3022352/ufp-technologies-ufpt-q3-earnings-and-revenues-surpass-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3022352) · Zacks Investment Research · Nov 3, 2026 · positive sentiment
- [Alphatec (ATEC) Q3 Earnings and Revenues Lag Estimates](https://www.zacks.com/stock/news/3019218/alphatec-atec-q3-earnings-and-revenues-lag-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3019218) · Zacks Investment Research · Oct 29, 2026 · negative sentiment
- [Johnson Fistel, PLLP Investigates Claims on Behalf of Long‑Term Shareholders of Quantum Computing Inc. (QUBT), Quanex Building Products Corporation (NX), Treace Medical Concepts, Inc. (TMCI), and BigBear.ai Holdings, Inc. (BBAI)](https://www.globenewswire.com/news-release/2025/12/01/3197528/0/en/Johnson-Fistel-PLLP-Investigates-Claims-on-Behalf-of-Long-Term-Shareholders-of-Quantum-Computing-Inc-QUBT-Quanex-Building-Products-Corporation-NX-Treace-Medical-Concepts-Inc-TMCI-a.html) · GlobeNewswire Inc. · Dec 1, 2025 · negative sentiment

## About Treace Medical Concepts, Inc. Common Stock

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 450 |
| Listed | Apr 23, 2021 |

[Company website](https://www.treace.com)

## FAQ

### What is the Treace Medical Concepts, Inc. Common Stock (TMCI) stock price today?

Treace Medical Concepts, Inc. Common Stock (TMCI) is trading at $4.44 (+0.45% on the day) as of 7:30:02 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Treace Medical Concepts, Inc. Common Stock?

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities.

### What is the short interest in TMCI?

As of Oct 30, 2026, TMCI has 1.79M shares short and 8.7 days to cover.

### What exchange is TMCI listed on?

Treace Medical Concepts, Inc. Common Stock (TMCI) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

## Live data

Prices here are 15-minute delayed. For real-time TMCI quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=TMCI`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Treace Medical Concepts, Inc. Common Stock (TMCI) insider trading](https://massive.com/quote/tmci/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
